Company Directory > Biotech > CRUK Scotland Institute
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of CRUK Scotland Institute and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
The CRUK Scotland Institute (formerly the CRUK Beatson Institute) is a premier cancer research center based in Glasgow, Scotland. It is core-funded by Cancer Research UK and focuses on investigating the molecular mechanisms of cancer development, with a strong emphasis on translating these discoveries into novel therapeutic opportunities for patients. The institute hosts approximately 250-300 researchers across 30 research groups. It maintains a robust translational pipeline, leveraging state-of-the-art in vitro and in vivo experimental models, advanced imaging, and mass spectrometry to support both fundamental discovery and industry-partnered preclinical projects.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Oncology Research
SIZE & FINANCIALS
Employees:201-500
Founded:2022
Ownership:nonprofit
Status:operating
FUNDING
Total Raised:£123M (7-year commitment from CRUK)
Investors:Cancer Research UK
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Small molecule, Cell therapy, Precision medicine
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Cancer Research UK
Key Partnerships:Ministry of Health of the Republic of Indonesia (Research collaboration), University of Glasgow (Academic partner), Various pharmaceutical industry partners for preclinical testing
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Owen Sansom - Scientific Director
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CRUK Scotland Institute. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.